Norway· NO-ID_85B12902-393F-451A-B7E3-62152E311AFB
Tafinlar
A dabrafenib product containing dabrafenib, registered in Norway by Novartis Europharm Limited (1). The same ATC class is registered in 14 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Dabrafenib is registered in 14 of 19 countries.
Countries holding a registration under ATC L01EC02 (dabrafenib), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Dabrafenib · ATC L01EC02
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dabrafenib costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Dabrafenib · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- CH Switzerland$232.39
The record
At a glance
FEST (Norway)- Active substance
- Dabrafenib
- Manufacturer
- Novartis Europharm Limited (1)
- Country
- Norway (NO)
- ATC code
- L01EC02
- ATC class
- Dabrafenib
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 5
2 priced- gtin7612797354148
- no_merkevare_idID_85B12902-393F-451A-B7E3-62152E311AFB
- no_varenummer40973228NOK 11427.6
- no_varenummer589153120NOK 47640.4
- gtin7612797354087
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
522 interactions on record for dabrafenib.
Graded by severity as the source publishes them — 79 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dabrafenib · interactions on record
522 records
- 79 severe
- 430 moderate
- 13 minor
Most severe, free to view
- LonafarnibA16AX20severe
- AvatrombopagB02BX08severe
- VoxelotorB06AX03severe
- RanolazineC01EB18severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dabrafenib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandTafinlarOrifarm Oy
- CzechiaTAFINLARNovartis Europharm Limited, Dublin
- SwitzerlandTafinlar 50 mg, HartkapselnNovartis Pharma Schweiz AG
- FranceTAFINLAR 50 mg, géluleNOVARTIS EUROPHARM (IRLANDE)
- United KingdomTafinlar 50mg capsulesNovartis Pharmaceuticals UK Ltd
- IrelandTafinlar 50 mg hard capsulesNovartis Europharm Limited
- IcelandTafinlarNovartis Europharm Limited*
- NetherlandsTafinlar 50 mg, harde capsulesNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Finlee, Tafinlar
- Liechtenstein · Finlee, Tafinlar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c445e12b-e954-4294-8293-7c7e47aa1c77 GET /v1/drugs/c445e12b-e954-4294-8293-7c7e47aa1c77?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsel, hard",
"source": "fest",
"status": "A",
"atc_name": "Dabrafenib",
"merkevare_id": "ID_85B12902-393F-451A-B7E3-62152E311AFB",
"name_form_strength": "Tafinlar kaps 50 mg",
"prescription_group": "C"
}See everything about dabrafenib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.